Alex Ray

5.7k total citations
21 papers, 510 citations indexed

About

Alex Ray is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Alex Ray has authored 21 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Alex Ray's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Viral-associated cancers and disorders (4 papers). Alex Ray is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Viral-associated cancers and disorders (4 papers). Alex Ray collaborates with scholars based in United States, Finland and Spain. Alex Ray's co-authors include Bridget Shafit‐Zagardo, Ross C. Gruber, Fernando Macián, Denise Whitby, Vickie Marshall, Nazzarena Labò, Peter H. Koo, Pablo Garcı́a de Frutos, John J. Cebra and Weizao Chen and has published in prestigious journals such as Science, The Journal of Chemical Physics and The Journal of Experimental Medicine.

In The Last Decade

Alex Ray

21 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Ray United States 12 210 203 152 96 62 21 510
Christi Parham United States 12 153 0.7× 242 1.2× 132 0.9× 90 0.9× 47 0.8× 14 645
Aude Guillabert Belgium 8 294 1.4× 271 1.3× 126 0.8× 163 1.7× 55 0.9× 8 649
J. Ludovic Croxford United States 12 149 0.7× 424 2.1× 74 0.5× 81 0.8× 40 0.6× 16 668
Sara Abromson‐Leeman United States 15 76 0.4× 401 2.0× 130 0.9× 35 0.4× 61 1.0× 26 564
Jeroen Bakker Netherlands 9 237 1.1× 109 0.5× 72 0.5× 75 0.8× 19 0.3× 12 518
Joanne C. Cooper United Kingdom 13 285 1.4× 461 2.3× 88 0.6× 50 0.5× 54 0.9× 16 795
Saša Radoja United States 14 166 0.8× 543 2.7× 240 1.6× 47 0.5× 26 0.4× 18 723
Sylvia Thelen Switzerland 14 276 1.3× 502 2.5× 483 3.2× 41 0.4× 57 0.9× 20 891
Laura I. Salazar‐Fontana United States 8 149 0.7× 312 1.5× 93 0.6× 36 0.4× 80 1.3× 10 499
Craig Hackett United States 8 674 3.2× 98 0.5× 239 1.6× 43 0.4× 57 0.9× 11 928

Countries citing papers authored by Alex Ray

Since Specialization
Citations

This map shows the geographic impact of Alex Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Ray more than expected).

Fields of papers citing papers by Alex Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Ray. The network helps show where Alex Ray may publish in the future.

Co-authorship network of co-authors of Alex Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Ray. A scholar is included among the top collaborators of Alex Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Ray. Alex Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Alex, et al.. (2020). Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 17(1). 324–324. 9 indexed citations
2.
Ray, Alex, Weizao Chen, Christina Ochsenbauer, et al.. (2019). Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model. Science Translational Medicine. 11(504). 117 indexed citations
3.
Ray, Alex, et al.. (2019). Akt3-Mediated Protection Against Inflammatory Demyelinating Disease. Frontiers in Immunology. 10. 34 indexed citations
4.
Mocholí, Enric, Yaïr Botbol, Ross C. Gruber, et al.. (2018). Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Reports. 24(5). 1136–1150. 45 indexed citations
6.
Gruber, Ross C., George P. Christophi, Chad A. Hudson, et al.. (2015). The control of reactive oxygen species production by SHP-1 in oligodendrocytes. Glia. 63(10). 1753–1771. 16 indexed citations
7.
Gruber, Ross C., et al.. (2014). Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis. Journal of Neuroscience. 34(49). 16320–16335. 56 indexed citations
8.
Marshall, Vickie, Eugene V. Barsov, Octavio A. Quiñones, et al.. (2013). Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Single-Nucleotide Polymorphisms Identified in Clinical Samples Can Affect MicroRNA Processing, Level of Expression, and Silencing Activity. Journal of Virology. 87(22). 12237–12248. 21 indexed citations
9.
Ray, Alex, Vickie Marshall, Thomas S. Uldrick, et al.. (2012). Sequence Analysis of Kaposi Sarcoma–Associated Herpesvirus (KSHV) MicroRNAs in Patients with Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome. The Journal of Infectious Diseases. 205(11). 1665–1676. 31 indexed citations
10.
Marshall, Vickie, Alex Ray, Thomas S. Uldrick, et al.. (2012). Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk. Infectious Agents and Cancer. 7(S1). 2 indexed citations
11.
Marshall, Vickie, Elisa Martró, Nazzarena Labò, et al.. (2010). Kaposi Sarcoma (KS)–Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European AIDS‐KS Case Control Study. The Journal of Infectious Diseases. 202(7). 1126–1135. 25 indexed citations
12.
Ray, Alex & Ross E. Rocklin. (1988). T- and B-cell-derived supernatant factors enhance IgE synthesis by a myeloma cell line (U-266). Cellular Immunology. 114(2). 293–306. 2 indexed citations
13.
Ray, Alex, et al.. (1987). Glucocorticoid-induced Enhancement of IgE Synthesis. Allergy and Asthma Proceedings. 8(2). 81–84. 7 indexed citations
14.
Devlin, J. Paul, et al.. (1981). Simple amorphous salts: Spectra and glass transition temperatures. The Journal of Chemical Physics. 74(9). 4774–4779. 4 indexed citations
15.
Ray, Alex, et al.. (1980). Antigen structural requirements for activation of a T-cell-mediated antibenzenearsonate immune response. Molecular Immunology. 17(8). 1011–1018. 1 indexed citations
16.
Ray, Alex, et al.. (1980). Recognition of DNP-amino acid determinants by primed guinea pig T cells. Cellular Immunology. 53(1). 173–181. 1 indexed citations
17.
Becker, Martin, Alex Ray, Leif C. Andersson, & O. Mäkelä. (1975). p‐Azobenzenearsonate‐L‐tyrosine‐mediated helper function in immune responses of guinea pigs and rats. European Journal of Immunology. 5(4). 262–266. 10 indexed citations
18.
Cebra, John J., Peter H. Koo, & Alex Ray. (1974). Specificity of Antibodies: Primary Structural Basis of Hapten Binding. Science. 186(4160). 263–265. 24 indexed citations
19.
Nakamura, Ichiro, Alex Ray, & O. Mäkelä. (1973). OLIGOMERIC IGA: THE MAJOR COMPONENT OF THE IN VITRO PRIMARY RESPONSE OF MOUSE SPLEEN FRAGMENTS. The Journal of Experimental Medicine. 138(4). 973–988. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026